EMA Panel Backs Generic for MS Drug Fingolimod (Gilenya) EMA Panel Backs Generic for MS Drug Fingolimod (Gilenya)

Studies have demonstrated bioequivalence of Fingolimod Accord to the reference product Gilenya for relapsing forms of multiple sclerosis, the EMA said.News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news